Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

Aethlon Medical Inc

+ Add to Watchlist

AEMD:US

0.2370 USD 0.0100 4.41%

As of 20:10:00 ET on 04/01/2015.

Snapshot for Aethlon Medical Inc (AEMD)

Open: 0.2420 Day's Range: 0.2250 - 0.2450 Volume: 486,369
Previous Close: 0.2270 52wk Range: 0.1025 - 0.7200 1-Yr Rtn: +23.44%

Stock Chart for AEMD

No chart data available.
  • AEMD:US 0.2370
  • 1D
  • 1M
  • 1Y
0.2270
Interactive AEMD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AEMD

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0360
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 78.28
Shares Outstanding (M) 330.30
30 Day Average Volume 976,534
Price/Book (mrq) 63.8233
Price/Sale (ttm) 43.2163
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AEMD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AEMD

Aethlon Medical, Inc. develops medical devices which treat infectious diseases. The Company's products include the Hemopurifier, which provides treatment against drug and vaccine resistant bioweapons, naturally evolving pandemic threats such as H5N1 Avian Flu, and chronic infectious disease targets including Hepatitis-C (HCV) and the Human Immunodeficiency Virus (HIV).

James A Joyce "Jim"Chairman/CEO/SecretaryRodney S Kenley "Rod"President
James B Frakes "Jim"Senior VP:Finance/CFORichard H TullisVP/Chief Science Officer
More Company Profile & Key Executives for AEMD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil